A volunteer of the clinical trial of Sputnik V (Gam-COVID-Vac) vaccine for nasal introduction, that has been developed by Gamalei Research Institute of Epidemiology and Microbiology, receives a doze of the vaccine in the University clinical hospital No 2 of the First Moscow State Medical University named after I. Sechenov in Moscow, Russia.
